Grant: Discovery Grants Program - Individual
Université Laval
$39,000.00
Decipher the physiological functions of osteoprotegerin in skeletal and cardiac muscles
EF 2023-24
Résumé
OVERVIEW: The main goal of our research program is to understand the cellular and molecular mechanisms underlying the crosstalk between muscles and bones under physiological and pathological conditions. The discovery of the receptor-activator of nuclear factor kB (RANK), receptor-activator of nuclear factor kB ligand (RANKL), and osteoprotegerin (OPG) triad (RANK/RANKL/OPG) was one of the most important advances in bone biology. While the biomechanical connection between skeletal muscle and bone tissues is obvious, we hypothesized a molecular crosstalk where the master regulator of bone homeostasis formed by the RANK/RANKL/OPG is important for synchronizing skeletal muscle, heart and bone communication. RECENT PROGRESS: Our previous works showed that muscle RANK plays a role in Ca2+ storage and muscle performance and that full-length OPG with the fragment crystallizable region of an antibody (FL-OPG-Fc), which contains RANKL-, TRAIL- and heparin-binding domains, potentiates dystrophic skeletal muscle function. We also discovered that genetic and pharmacological manipulations of the RANKL/RANK interaction improve, to a lesser extent than FL-OPG-Fc, dystrophic muscle contractility suggesting that FL-OPG-Fc acts also independently of RANKL inhibition. We also highlighted that skeletal muscle cells secrete OPG which is now recognized as a myokine. In line with a previous report, we observe that mice deficient in OPG present cardiac hypertrophy as early as 2.5 months of age. These compelling results indicate the implication of the RANK/RANKL/OPG triad in skeletal and cardiac muscle function. SPECIFIC OBJECTIVES: The present project will first explore the cellular and physiological impact of FL-OPG-Fc on myocardium. Secondly, we will investigate the interactions between FL-OPG-Fc and cell surface proteins and the cell signaling pathways involved in skeletal and cardiac muscle function. Thirdly, we will characterize the importance of the heparin binding domain of OPG in cell surface interactions using a selective triple amino acid mutation in the OPG protein. The results generated will demonstrate that FL-OPG-Fc and in particular its heparin binding domain play a unique role in skeletal and cardiac muscle function. CONCLUSION: Our research program has been productive in terms of knowledge advancements, scientific publications, generation of new ideas and graduate student training and mentorship. The current research program focusing on OPG may lead to the discovery of key molecular signaling pathways that regulate the size and function of skeletal and cardiac muscles. Importantly, this renewal application will contribute to training HQP in a field that has the potential to become transformative for academia as well as public and private sectors. Our research program will also ensure the development of the next generation of Canadian scientists in an equitable, diverse and inclusive environment.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2023-04080
Name nom
Frenette, Jérôme
Department département
Réadaptation
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
39000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Not available
Research subject en
Non disponible
Research subject fr
Non disponible
Application title
Decipher the physiological functions of osteoprotegerin in skeletal and cardiac muscles
Keyword
atrophy; calcium; cardiac muscle; contractility; full length osteoprotegerin; heart hypertrophy; muscle function; RANK/RANKL/OPG; SERCA; skeletal muscle
Application summary
OVERVIEW: The main goal of our research program is to understand the cellular and molecular mechanisms underlying the crosstalk between muscles and bones under physiological and pathological conditions. The discovery of the receptor-activator of nuclear factor kB (RANK), receptor-activator of nuclear factor kB ligand (RANKL), and osteoprotegerin (OPG) triad (RANK/RANKL/OPG) was one of the most important advances in bone biology. While the biomechanical connection between skeletal muscle and bone tissues is obvious, we hypothesized a molecular crosstalk where the master regulator of bone homeostasis formed by the RANK/RANKL/OPG is important for synchronizing skeletal muscle, heart and bone communication. RECENT PROGRESS: Our previous works showed that muscle RANK plays a role in Ca2+ storage and muscle performance and that full-length OPG with the fragment crystallizable region of an antibody (FL-OPG-Fc), which contains RANKL-, TRAIL- and heparin-binding domains, potentiates dystrophic skeletal muscle function. We also discovered that genetic and pharmacological manipulations of the RANKL/RANK interaction improve, to a lesser extent than FL-OPG-Fc, dystrophic muscle contractility suggesting that FL-OPG-Fc acts also independently of RANKL inhibition. We also highlighted that skeletal muscle cells secrete OPG which is now recognized as a myokine. In line with a previous report, we observe that mice deficient in OPG present cardiac hypertrophy as early as 2.5 months of age. These compelling results indicate the implication of the RANK/RANKL/OPG triad in skeletal and cardiac muscle function. SPECIFIC OBJECTIVES: The present project will first explore the cellular and physiological impact of FL-OPG-Fc on myocardium. Secondly, we will investigate the interactions between FL-OPG-Fc and cell surface proteins and the cell signaling pathways involved in skeletal and cardiac muscle function. Thirdly, we will characterize the importance of the heparin binding domain of OPG in cell surface interactions using a selective triple amino acid mutation in the OPG protein. The results generated will demonstrate that FL-OPG-Fc and in particular its heparin binding domain play a unique role in skeletal and cardiac muscle function. CONCLUSION: Our research program has been productive in terms of knowledge advancements, scientific publications, generation of new ideas and graduate student training and mentorship. The current research program focusing on OPG may lead to the discovery of key molecular signaling pathways that regulate the size and function of skeletal and cardiac muscles. Importantly, this renewal application will contribute to training HQP in a field that has the potential to become transformative for academia as well as public and private sectors. Our research program will also ensure the development of the next generation of Canadian scientists in an equitable, diverse and inclusive environment.